Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes (Q38760067)

6 September 2017

title

Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes (English)

1 reference

6 September 2017

Bianca Rocca

1

1 reference

6 September 2017

Steen Husted

series ordinal

2

1 reference

6 September 2017

publication date

3 March 2016

1 reference

6 September 2017

1 reference

6 September 2017

volume

33

1 reference

6 September 2017

issue

4

1 reference

6 September 2017

page(s)

233-248

1 reference

Increasing Sibling Relative Risk of Survival to Older and Older Ages and the Importance of Precise Definitions of "Aging," "Life Span," and "Longevity".

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Genetic and environmental influences on exceptional longevity and the AGE nomogram

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Effects of aging on blood brain barrier and matrix metalloproteases following controlled cortical impact in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Heart Disease and Stroke Statistics--2015 Update: A Report From the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Predictors of major bleeding in acute coronary syndromes: the Global Registry of Acute Coronary Events (GRACE).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevati

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Reduced platelet thromboxane formation in uremia. Evidence for a functional cyclooxygenase defect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

In-hospital and 1-year outcomes among percutaneous coronary intervention patients with chronic kidney disease in the era of drug-eluting stents: a report from the EVENT (Evaluation of Drug Eluting Stents and Ischemic Events) registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Predictive value of the HAS-BLED and ATRIA bleeding scores for the risk of serious bleeding in a "real-world" population with atrial fibrillation receiving anticoagulant therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Hemostasis factors and aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Intracerebral hemorrhage: a review of coagulation function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Thrombomodulin as a marker for bleeding complications during warfarin treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Prasugrel versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Acquired skewing of X‐chromosome inactivation patterns in myeloid cells of the elderly suggests stochastic clonal loss with age

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

The aging bone marrow and its impact on immune responses in old age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Anemia in the elderly: how should we define it, when does it matter, and what can be done?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Effect of anemia on frequency of short- and long-term clinical events in acute coronary syndromes (from the Acute Catheterization and Urgent Intervention Triage Strategy Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Platelet count and aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Complete blood count reference intervals and age- and sex-related trends of North China Han population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

The role of apoptosis in megakaryocytes and platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Human platelet microRNA-mRNA networks associated with age and gender revealed by integrated plateletomics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Change in protein phenotype without a nucleus: translational control in platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Response to prasugrel and levels of circulating reticulated platelets in patients with ST-segment elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Reticulated platelets: analytical aspects and clinical utility

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Aging, arterial stiffness, and hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Arterial stiffness in patients with deep and lobar intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Silent cerebral microbleeds associated with arterial stiffness in an apparently healthy subject

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Cerebral amyloid angiopathy: emerging concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Matrix metalloproteinase-9: dual role and temporal profile in intracerebral hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Geriatric drug therapy: neglecting the inevitable majority

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Aging biology and geriatric clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

The influence of age and sex on the clearance of cytochrome P450 3A substrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

The current state of knowledge on age, sex, and their interactions on clinical pharmacology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Age-dependent changes of the kidneys: pharmacological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Review on pharmacokinetics and pharmacodynamics and the aging kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Risk of bleeding associated with combined use of selective serotonin reuptake inhibitors and antiplatelet therapy following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Polypharmacy is associated with an increased risk of bleeding in elderly patients with venous thromboembolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Oral anticoagulation in elderly adults with atrial fibrillation: integrating new options with old concepts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

The exclusion of patients with chronic kidney disease from clinical trials in coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Platelet response to low-dose enteric-coated aspirin in patients with stable cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Are the antiplatelet and profibrinolytic properties of selective serotonin-reuptake inhibitors relevant to their brain effects?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Prasugrel versus clopidogrel for acute coronary syndromes without revascularization

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Ticagrelor versus clopidogrel in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Long-term use of ticagrelor in patients with prior myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Biomarkers in relation to the effects of ticagrelor in comparison with clopidogrel in non-ST-elevation acute coronary syndrome patients managed with or without in-hospital revascularization: a substudy from the Prospective Randomized Platelet Inhibi

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Structural and functional characterization of a specific antidote for ticagrelor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Vorapaxar for secondary prevention of thrombotic events for patients with previous myocardial infarction: a prespecified subgroup analysis of the TRA 2°P-TIMI 50 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Vorapaxar in the secondary prevention of atherothrombotic events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Thrombin-receptor antagonist vorapaxar in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Inhibition of the platelet glycoprotein IIb/IIIa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Age, treatment, and outcomes in high-risk non-ST-segment elevation acute coronary syndrome patients: insights from the EARLY ACS trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

A risk score to predict bleeding in patients with acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Safety and effectiveness of antithrombotic strategies in older adult patients with atrial fibrillation and non-ST elevation myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Triple therapy for percutaneous coronary intervention in atrial fibrillation: standard of care, or a nightmare soon to end?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Warfarin use among older atrial fibrillation patients with non-ST-segment elevation myocardial infarction managed with coronary stenting and dual antiplatelet therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Use and Outcomes of Triple Therapy Among Older Patients With Acute Myocardial Infarction and Atrial Fibrillation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Double-dose versus standard-dose clopidogrel and high-dose versus low-dose aspirin in individuals undergoing percutaneous coronary intervention for acute coronary syndromes (CURRENT-OASIS 7): a randomised factorial trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Concomitant use of antiplatelet therapy with dabigatran or warfarin in the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Apixaban with antiplatelet therapy after acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Comparison of fondaparinux and enoxaparin in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Efficacy and safety of fondaparinux in patients with ST-segment elevation myocardial infarction across the age spectrum. Results from the Organization for the Assessment of Strategies for Ischemic Syndromes 6 (OASIS-6) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Outcomes in elderly patients with acute coronary syndromes randomized to enoxaparin vs. unfractionated heparin: results from the SYNERGY trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Enoxaparin vs. unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction in elderly and younger patients: results from ExTRACT-TIMI 25.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Preinjury warfarin, but not antiplatelet medications, increases mortality in elderly traumatic brain injury patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Impact of preinjury warfarin and antiplatelet agents on outcomes of trauma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Effects of antiplatelet agents on outcomes for elderly patients with traumatic intracranial hemorrhage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

A meta-analysis to determine the effect of preinjury antiplatelet agents on mortality in patients with blunt head trauma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

2012 ACCF/AHA focused update of the guideline for the management of patients with unstable angina/non-ST-elevation myocardial infarction (updating the 2007 guideline and replacing the 2011 focused update): a report of the American College of Cardiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Bivalirudin and provisional glycoprotein IIb/IIIa blockade compared with heparin and planned glycoprotein IIb/IIIa blockade during percutaneous coronary intervention: REPLACE-2 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Advanced age, antithrombotic strategy, and bleeding in non-ST-segment elevation acute coronary syndromes: results from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Bivalirudin started during emergency transport for primary PCI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Abciximab and Heparin versus Bivalirudin for Non–ST-Elevation Myocardial Infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Incidence, Prognostic Impact, and Influence of Antithrombotic Therapy on Access and Nonaccess Site Bleeding in Percutaneous Coronary Intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

Von Willebrand factor predicts major bleeding and mortality during oral anticoagulant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

d-dimer predicts major bleeding, cardiovascular events and all-cause mortality during warfarin treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S40266-016-0359-0

American Geriatrics Society 2015 Updated Beers Criteria for Potentially Inappropriate Medication Use in Older Adults

21 January 2018

1 reference

12 December 2020

The relationship between number of drugs and potential drug-drug interactions in the elderly: a study of over 600,000 elderly patients from the Swedish Prescribed Drug Register

1 reference

12 December 2020

An overview of PCI in the very elderly

1 reference

12 December 2020

Relationship between exposure to prasugrel active metabolite and clinical outcomes in the TRITON-TIMI 38 substudy

1 reference

12 December 2020

Mean platelet volume is highly correlated to platelet count

1 reference

12 December 2020

Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.

1 reference

12 December 2020

Comparison of the efficacy and safety of two rivaroxaban doses in acute coronary syndrome (from ATLAS ACS 2-TIMI 51)

1 reference

12 December 2020

The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes

1 reference

12 December 2020

Fat and protein redistribution with aging: metabolic considerations.

1 reference

12 December 2020

Ticagrelor Versus Clopidogrel in Elderly Patients With Acute Coronary Syndromes

1 reference

12 December 2020

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary

1 reference

12 December 2020

An open-label, randomized, controlled, multicenter study exploring two treatment strategies of rivaroxaban and a dose-adjusted oral vitamin K antagonist treatment strategy in subjects with atrial fibrillation who undergo percutaneous coronary interv

1 reference

12 December 2020

Age-dependent effect of abciximab in patients with acute coronary syndromes treated with percutaneous coronary interventions

1 reference

12 December 2020

Blood rheology and aging

1 reference

12 December 2020

Functional and anatomic evaluation of carotid atherothrombosis. A combined study of indium 111 platelet scintigraphy and B-mode ultrasonography

1 reference

12 December 2020

Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation

1 reference

12 December 2020

Increased mean platelet volume is associated with non-responsiveness to clopidogrel

1 reference

12 December 2020

Effect on lifespan of high yield non-myeloablating transplantation of bone marrow from young to old mice

1 reference

12 December 2020

Outcomes in traumatic brain injury for patients presenting on antiplatelet therapy

1 reference

12 December 2020

Dual antiplatelet therapy versus oral anticoagulation plus dual antiplatelet therapy in patients with atrial fibrillation and low-to-moderate thromboembolic risk undergoing coronary stenting: Design of the MUSICA-2 randomized trial

1 reference

12 December 2020

10.1007/S40266-016-0359-0

Identifiers

DOI

1 reference

6 September 2017

1 reference